Absci (ABSI) Accumulated Expenses (2020 - 2025)
Absci (ABSI) reported Accumulated Expenses of $8.2 million for Q3 2025, down 54.9% on a YoY basis from $18.2 million in Q3 2024, and up 43.99% sequentially from $5.7 million in Q2 2025.
Absci (ABSI) Accumulated Expenses (2020 - 2025) Analysis & Trends
Absci (ABSI) has 6 years of Accumulated Expenses data on file, last reported at $8.2 million in Q3 2025.
- For the quarter ending Q3 2025, Accumulated Expenses fell 54.9% year-over-year to $8.2 million; the trailing twelve-month figure through Sep 2025 stood at $8.2 million (down 54.9% YoY), and the FY2024 full-year result was $6.8 million, up 4.41% from the prior year.
- Accumulated Expenses rose to $8.2 million in Q3 2025, from $5.7 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $25.6 million in Q1 2022 to a low of $4.3 million in Q1 2025.
- A 5-year average of $14.9 million and a median of $16.8 million in 2023 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses surged 1011.15% in 2021 and plunged 72.36% in 2025, its largest moves.
- Tracing ABSI's Accumulated Expenses over 5 years: stood at $17.4 million in 2021, then grew by 17.48% to $20.5 million in 2022, then plunged by 68.0% to $6.6 million in 2023, then advanced by 4.41% to $6.8 million in 2024, then gained by 20.27% to $8.2 million in 2025.
- Business Quant data shows ABSI's Accumulated Expenses at $8.2 million in Q3 2025, $5.7 million in Q2 2025, and $4.3 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 8.23 Mn |
| Jun 30, 2025 | 5.72 Mn |
| Mar 31, 2025 | 4.26 Mn |
| Dec 31, 2024 | 6.84 Mn |
| Sep 30, 2024 | 18.25 Mn |
| Jun 30, 2024 | 16.85 Mn |
| Mar 31, 2024 | 15.40 Mn |
| Dec 31, 2023 | 6.55 Mn |
| Sep 30, 2023 | 19.68 Mn |
| Jun 30, 2023 | 16.71 Mn |
| Mar 31, 2023 | 18.09 Mn |
| Dec 31, 2022 | 20.48 Mn |
| Sep 30, 2022 | 20.98 Mn |
| Jun 30, 2022 | 17.05 Mn |
| Mar 31, 2022 | 25.64 Mn |
| Dec 31, 2021 | 17.43 Mn |
| Sep 30, 2021 | 15.28 Mn |
| Jun 30, 2021 | 14.00 Mn |
| Dec 31, 2020 | 1.57 Mn |